{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:23:44Z","timestamp":1791051824189,"version":"4.1.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuropathol Exp Neurol"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1093\/jnen\/59.4.308","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T23:38:33Z","timestamp":1452555513000},"page":"308-313","source":"Crossref","is-referenced-by-count":135,"title":["The Cholinergic Deficit Coincides with A\u03b2 Deposition at the Earliest Histopathologic Stages of Alzheimer Disease"],"prefix":"10.1093","volume":"59","author":[{"given":"Thomas G.","family":"Beach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Min","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharyn","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Emmerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia I.","family":"Sue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Kokjohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex E.","family":"Roher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2000,4,1]]},"reference":[{"key":"2016011115382554000_59.4.308.1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.21.1.479"},{"key":"2016011115382554000_59.4.308.2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(82)90026-0"},{"key":"2016011115382554000_59.4.308.3","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(88)90118-9"},{"key":"2016011115382554000_59.4.308.4","doi-asserted-by":"publisher","DOI":"10.1007\/s004010050595"},{"key":"2016011115382554000_59.4.308.5","first-page":"375","article-title":"Neurofibrillary tangles are constant in aging human nucleus basalis","volume":"1","author":"Beach","year":"1998","journal-title":"Alzheimer's Reports"},{"key":"2016011115382554000_59.4.308.6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410230206"},{"key":"2016011115382554000_59.4.308.7","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): Current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"2016011115382554000_59.4.308.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(96)01363-7"},{"key":"2016011115382554000_59.4.308.9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.26.12260"},{"key":"2016011115382554000_59.4.308.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511093331902"},{"key":"2016011115382554000_59.4.308.11","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199803000-00005"},{"key":"2016011115382554000_59.4.308.12","first-page":"479","article-title":"The consortium to establish a registry for Alzheimer's disease (CERAD)","volume":"41","author":"Mirra","year":"1991","journal-title":"Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology"},{"key":"2016011115382554000_59.4.308.13","doi-asserted-by":"publisher","DOI":"10.1007\/BF00308809"},{"key":"2016011115382554000_59.4.308.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.1991.tb00661.x"},{"key":"2016011115382554000_59.4.308.15","doi-asserted-by":"publisher","DOI":"10.1042\/bj1150465"},{"key":"2016011115382554000_59.4.308.16","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9652"},{"key":"2016011115382554000_59.4.308.17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.13.7013"},{"key":"2016011115382554000_59.4.308.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(97)00966-X"},{"key":"2016011115382554000_59.4.308.19","first-page":"121","article-title":"Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide","volume":"2","author":"Kim","year":"1988","journal-title":"Neurosci Res Comm"},{"key":"2016011115382554000_59.4.308.20","first-page":"113","article-title":"Detection and quantitation of amyloid \u03b2-peptide with 2 monoclonal antibodies","volume":"7","author":"Kim","year":"1990","journal-title":"Neurosci Res Comm"},{"key":"2016011115382554000_59.4.308.21","first-page":"459","article-title":"Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies","volume":"99","author":"Bowen","year":"1976","journal-title":"Brain Res"},{"key":"2016011115382554000_59.4.308.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)91936-X"},{"key":"2016011115382554000_59.4.308.23","doi-asserted-by":"crossref","unstructured":"Perry EK Perry RH Blessed G Tomlinson BE . Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1977;189","DOI":"10.1016\/S0140-6736(77)91780-9"},{"key":"2016011115382554000_59.4.308.24","first-page":"139","article-title":"Anterograde vs retrograde degeneration of the nucleus basalis medialis in Alzheimer's disease","volume":"(Suppl) 24","author":"Pearson","year":"1987","journal-title":"J Neural Transm"},{"key":"2016011115382554000_59.4.308.25","unstructured":"Geula C Mesulam M-M . Cholinergic sysems and related neuropathological predilection patterns in Alzheimer disease. In: Terry RD Katzman R Bick KL , eds. Alzheimer disease. New York: Raven Press, 1994:263\u201391"},{"key":"2016011115382554000_59.4.308.26","doi-asserted-by":"crossref","first-page":"10987","DOI":"10.1016\/S0021-9258(19)78080-6","article-title":"Chemical characterization of A\u03b2 17\u201342 peptide, a component of diffuse amyloid deposits of Alzheimer disease","volume":"269","author":"Gowing","year":"1994","journal-title":"J Biol Chem"},{"key":"2016011115382554000_59.4.308.27","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(94)90458-8"},{"key":"2016011115382554000_59.4.308.28","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(95)02062-4"},{"key":"2016011115382554000_59.4.308.29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.15.1401"},{"key":"2016011115382554000_59.4.308.30","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X"},{"key":"2016011115382554000_59.4.308.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.21.10075"},{"key":"2016011115382554000_59.4.308.32","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.8235"},{"key":"2016011115382554000_59.4.308.33","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0024-3205(95)02064-P","article-title":"The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from chinese hamster ovary-m1 cells","volume":"12","author":"Eckols","year":"1995","journal-title":"Life Sci"},{"key":"2016011115382554000_59.4.308.34","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.1523\/JNEUROSCI.15-11-07442.1995","article-title":"Regulated secretion of \u03b2-amyloid precursor protein in rat brain","volume":"15","author":"Farber","year":"1995","journal-title":"J Neurosci"},{"key":"2016011115382554000_59.4.308.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(97)00038-6"},{"key":"2016011115382554000_59.4.308.36","doi-asserted-by":"publisher","DOI":"10.1126\/science.1411529"},{"key":"2016011115382554000_59.4.308.37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.9.4916"},{"key":"2016011115382554000_59.4.308.38","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(92)90113-C"},{"key":"2016011115382554000_59.4.308.39"},{"key":"2016011115382554000_59.4.308.40","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.11.1688"},{"key":"2016011115382554000_59.4.308.41","doi-asserted-by":"publisher","DOI":"10.1038\/373523a0"},{"key":"2016011115382554000_59.4.308.42","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5284.99"},{"key":"2016011115382554000_59.4.308.43","first-page":"2117","article-title":"The cholinergic system in a transgenic mouse model of Alzheimer's disease","volume":"25","author":"Westerman","year":"1999","journal-title":"Soc Neurosci Abs"},{"key":"2016011115382554000_59.4.308.44","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1523\/JNEUROSCI.19-07-02706.1999","article-title":"Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes","volume":"19","author":"Wong","year":"1999","journal-title":"J Neurosci"},{"key":"2016011115382554000_59.4.308.45","first-page":"1292","article-title":"Immunotoxin-induced cortical cholinergic denervation leads to vascular \u03b2-amyloid deposition: A model of cerebral amyloid angiopathy","volume":"25","author":"Potter","year":"1999","journal-title":"Soc Neurosci Abs"},{"key":"2016011115382554000_59.4.308.46","first-page":"400","article-title":"Long term treatment of senile dementia with oral physostigmine","volume":"49","author":"Beller","year":"1988","journal-title":"J. Clin Psychiatr"},{"key":"2016011115382554000_59.4.308.47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199210293271801"},{"key":"2016011115382554000_59.4.308.48","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.9.1350"},{"key":"2016011115382554000_59.4.308.49","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199040400-00004"},{"key":"2016011115382554000_59.4.308.50","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510370037029"},{"key":"2016011115382554000_59.4.308.51","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.1.166"},{"key":"2016011115382554000_59.4.308.52","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.12.1837"},{"key":"2016011115382554000_59.4.308.53","first-page":"17","article-title":"The effect of tacrine and lecithin in Alzheimer's disease","volume":"47","author":"Holford","year":"1994","journal-title":"A population pharmacodynamic analysis of five clinical trials. Eur J Clin Pharmacol"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnen\/article-pdf\/59\/4\/308\/8132637\/59-4-308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T11:26:18Z","timestamp":1654082778000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article-lookup\/doi\/10.1093\/jnen\/59.4.308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2000,4,1]]},"published-print":{"date-parts":[[2000,4]]}},"alternative-id":["10.1093\/jnen\/59.4.308"],"URL":"https:\/\/doi.org\/10.1093\/jnen\/59.4.308","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}